Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib and Sirolimus in Advanced NSCLC
NCT00098462Phase 2Withdrawn
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Oct 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sirolimus in non-small cell lung cancer (NSCLC), sponsored by UCLA Jonsson Comprehensive Cancer Center. Planned start Oct 2004; status: withdrawn.
02
Drugs
sirolimus
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00098462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098462.